Linguamatics

Linguamatics' I2E natural language processing engine helps Sanofi match HLA alleles with multiple sclerosis and associated drug treatments.

Version 5.0 of the software features tools for normalizing concepts such as gene mutations and additional query features for mining text documents.

CollabRx has launched CancerRx, a new oncology application that runs on Apple's operating system. The app provides oncologists and pathologists with treatment options that are based on their patients' tumors and also offers a daily newsfeed from MedPage Today.

RefSeq 65 is now available from the National Center for Biotechnology Information via FTP.

Linguamatics said this week that it exceeded $10 million in sales last year outperforming both growth and sales expectations.

Linguamatics said this week that researchers at the University of Utah's Huntsman Cancer Institute are using Linguamatics I2E, the company's text mining software solution, to extract information from electronic health records that could help them better understand cancer and impr

Agilent Technologies has released a new version of its electronic laboratory notebook software.

The TranSMART Foundation has launched a new version of the open source knowledge management platform.

Text mining software developer Linguamatics has been selected as a commercial partner in a two-year research project funded by the European Commission’s Seventh Framework Program that is focused on improving multilingual terminologies in biomedicine.

Informatics startup Code-N has launched an early-access program that will allow pharmaceutical companies to test-drive Green Field Finder, its cloud-based semantic software that helps researchers search the patent databases to assess the competitive opportunity for drug candidate

Pages

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.